BiomeSense

BiomeSense

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15.1M

Overview

BiomeSense is a microbiome data infrastructure company building a proprietary platform to generate and analyze continuous, high-resolution gut microbiome data. The company's technology integrates the GutLab system for at-home sample collection and the MetaBiome AI platform for advanced time-series analysis, targeting the limitations of current costly and sparse microbiome sampling. BiomeSense partners with research institutions and biopharma companies to support exploratory research, biomarker discovery, and product development in the microbiome space, positioning the gut microbiome as a next frontier in precision medicine.

Oncology

Technology Platform

Integrated platform combining GutLab (hardware for continuous, at-home microbiome sample collection) and MetaBiome (AI-enabled bioinformatics platform for longitudinal time-series analysis of microbiome data).

Funding History

2
Total raised:$15.1M
Series A$12M
Seed$3.1M

Opportunities

The growing microbiome market creates demand for robust data generation tools.
BiomeSense's platform is uniquely positioned to enable biomarker discovery and patient stratification in drug development, particularly in high-stakes areas like oncology.
Partnerships with pharmaceutical companies represent a significant near-term revenue opportunity.

Risk Factors

Market adoption risk, as researchers may be slow to shift from traditional, cheaper sampling methods.
Technical execution risk in scaling its hardware and validating its AI analytics across diverse populations.
Financial risk as a pre-revenue startup dependent on external funding in a competitive capital environment.

Competitive Landscape

Competition includes large sequencing service providers (e.g., Illumina, Qiagen), contract research organizations (CROs) offering microbiome analysis, and other startups focused on microbiome sampling or AI analytics. BiomeSense differentiates through its integrated focus on continuous, longitudinal data capture and specialized time-series AI.